Health
Physicians debate focal therapy as alternative treatment for localized prostate cancer
Targeted therapies aim to spare healthy tissue and reduce side effects, though standard guidelines still consider them experimental.
The short version
- Focal therapy targets specific MRI-visible lesions in prostate cancer rather than removing or irradiating the entire gland.
- The approach aims to reduce severe long-term complications, including erectile dysfunction and incontinence.
- Official clinical treatment guidelines continue to classify focal therapy as experimental, leaving physicians divided over its role.
Key facts
- Standard treatment for localized prostate cancer typically entails complete surgical removal or whole-gland radiation.[STAT]
- Whole-gland treatments carry known risks of severe long-term side effects, particularly urinary incontinence and erectile dysfunction.[STAT]
- Focal therapy uses methods such as extreme heat, freezing, or electrical currents directed at lesions visible on MRI scans.[STAT]
- Focal procedures can often be performed in a single session and sometimes within an outpatient doctor's office.[STAT]
- Established clinical practice guidelines still categorize focal therapy as an experimental approach.[STAT]
What remains uncertain
- Whether incoming clinical data will provide sufficient evidence to shift treatment guidelines away from an experimental designation remains undetermined.[STAT]